BEAM
Price
$31.00
Change
-$1.68 (-5.14%)
Updated
Jul 13 closing price
Capitalization
3.19B
28 days until earnings call
Intraday BUY SELL Signals
VIR
Price
$9.72
Change
-$0.24 (-2.41%)
Updated
Jul 13 closing price
Capitalization
1.64B
16 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs VIR

BEAM vs VIR Comparison Chart in %
View a ticker or compare two or three
VS
BEAM vs. VIR commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and VIR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (BEAM: $31.00 vs. VIR: $9.72)
Brand notoriety: BEAM and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 77% vs. VIR: 67%
Market capitalization -- BEAM: $3.19B vs. VIR: $1.64B
BEAM [@Biotechnology] is valued at $3.19B. VIR’s [@Biotechnology] market capitalization is $1.64B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileVIR’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • VIR’s FA Score: 1 green, 4 red.
According to our system of comparison, VIR is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while VIR’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • VIR’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than VIR.

Price Growth

BEAM (@Biotechnology) experienced а -12.23% price change this week, while VIR (@Biotechnology) price change was -2.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 11, 2026.

VIR is expected to report earnings on Jul 30, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($3.19B) has a higher market cap than VIR($1.64B). VIR YTD gains are higher at: 61.194 vs. BEAM (11.833). BEAM has higher annual earnings (EBITDA): -349.25M vs. VIR (-460.62M). BEAM has more cash in the bank: 1.21B vs. VIR (476M). VIR has less debt than BEAM: VIR (95.6M) vs BEAM (251M). BEAM has higher revenues than VIR: BEAM (164M) vs VIR (64.7M).
BEAMVIRBEAM / VIR
Capitalization3.19B1.64B195%
EBITDA-349.25M-460.62M76%
Gain YTD11.83361.19419%
P/E RatioN/AN/A-
Revenue164M64.7M253%
Total Cash1.21B476M255%
Total Debt251M95.6M263%
FUNDAMENTALS RATINGS
BEAM vs VIR: Fundamental Ratings
BEAM
VIR
OUTLOOK RATING
1..100
8168
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
56
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9399
PRICE GROWTH RATING
1..100
4138
P/E GROWTH RATING
1..100
10031
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BEAM's Valuation (27) in the null industry is in the same range as VIR (56). This means that BEAM’s stock grew similarly to VIR’s over the last 12 months.

BEAM's Profit vs Risk Rating (100) in the null industry is in the same range as VIR (100). This means that BEAM’s stock grew similarly to VIR’s over the last 12 months.

BEAM's SMR Rating (93) in the null industry is in the same range as VIR (99). This means that BEAM’s stock grew similarly to VIR’s over the last 12 months.

VIR's Price Growth Rating (38) in the null industry is in the same range as BEAM (41). This means that VIR’s stock grew similarly to BEAM’s over the last 12 months.

VIR's P/E Growth Rating (31) in the null industry is significantly better than the same rating for BEAM (100). This means that VIR’s stock grew significantly faster than BEAM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BEAMVIR
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 18 days ago
76%
Bullish Trend 21 days ago
74%
Declines
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
81%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
79%
Aroon
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signal:
Gain/Loss:
VIR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SRTY23.000.57
+2.54%
ProShares UltraPro Short Russell2000
BSCS20.36N/A
N/A
Invesco BulletShares 2028 Corp Bd ETF
RDTL25.88N/A
N/A
GraniteShares 2x Long RDDT Daily ETF
FETH17.66-0.20
-1.12%
Fidelity Ethereum Fund
FDG131.29-2.57
-1.92%
American Century Foc Dynmc Gr ETF

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with BEAM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
-2.41%
BEAM - VIR
54%
Loosely correlated
-5.14%
PCVX - VIR
52%
Loosely correlated
-2.03%
DNLI - VIR
51%
Loosely correlated
+3.12%
RCUS - VIR
50%
Loosely correlated
-2.94%
XNCR - VIR
50%
Loosely correlated
-5.62%
More